Daedalus | 4D biomAteriaLs for mucosa and sub-mUcosa treatment

ADvAncEd 4D biomAteriaLs for mucosa and sub-mUcosa treatment in patients affected by intestinal diSeases

Find out more

48

Months

13

Partners

7 760 778.22

EU Contribution

Advanced Materials

Design of photo-crosslinkable, biodegradable biomaterials with self-healing, shape-morphing and bioactive properties.

Smart Drug Delivery

Controlled release of oxygen, glucose, growth factors and antibacterial agents to support tissue healing.

Endoscopic Innovation

Development of a novel toolhead for in situ injection and activation of the biomaterials, compatible with clinical endoscopes.

Human-Centred Innovation

Focus on improving quality of life for patients through personalised, less invasive treatments.

DAEDALUS is redefining tissue regeneration using 4D biomaterials and smart endoscopic delivery systems.

Pioneering minimally invasive solutions for colorectal diseases

DAEDALUS is a Horizon Europe-funded research project aiming to transform the treatment of colorectal diseases (CRDs) through a new generation of minimally invasive, regenerative solutions. These diseases, such as ulcerative colitis and familial adenomatous polyposis, currently require invasive surgery with serious long-term consequences.

Explore how DAEDALUS is transforming regenerative medicine

The project brings together leading researchers, clinicians, and engineers across Europe, combining expertise in nanotechnology, medical engineering, and in situ bioprinting.

Learn more